SK Chemicals licenses influenza vaccine technology to Sanofi Pasteur for US$155 mln
SK Chemicals Co., a South Korean vaccine maker, said Monday that it has signed a US$155 million deal to license its vaccine technology to Sanofi Pasteur Inc.
SK Chemicals licenses influenza vaccine technology to Sanofi Pasteur for US5 mln
Source: Virology News